Banner for leaf pages 2

Vemurafenib (Zelboraf)

Also known as Zelboraf

Vemurafenib (INN, marketed as Zelboraf) is a B-Raf enzyme inhibitor developed by Plexxikon (now part of the Daiichi Sankyo group) and Genentech for the treatment of late-stage melanoma. The name "vemurafenib" comes from V600E mutated BRAF inhibition.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed vemurafenib to treat rabies, blastomycosis, west nile virus, and pick disease.

What drug interactions are known?

Do not take vemurafenib if you are taking any of the following:

Critical Interactions


Significant Interactions

Ajax-loader Loading...